// App-Quantinova.ai

1602 : Development and validation of an NGS-based assay to detect all classes of genomic alterations in circulating tumor cells (CTCs) from patients with solid tumors

Researchers

Presenter

  • Allison Welsh

Principal Investigators

  • Garrett M. Frampton

  • Zachary R. Chalmers

  • David J. Beebe

  • Vincent A. Miller

  • Joshua M. Lang

  • Philip J. Stephens

  • Jamie Sperger

  • Roman Yelensky

  • Doron Lipson

  • Geoff Otto

  • Lindsay Strotman

  • Scott Berry

  • Hannah Pezzi

  • Anne Traynor

Medical Centers

  • Foundation Medicine, Inc, Cambridge, MA

  • Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI

  • Department of Biomedical Engineering, University of Wisconsin, Madison, WI

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

  • Breast cancer

  • Solid malignancies

  • Lung Cancer

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved